| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6234903
[patent_doc_number] => 20100266607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT'
[patent_app_type] => utility
[patent_app_number] => 12/753438
[patent_app_country] => US
[patent_app_date] => 2010-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18508
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266607.pdf
[firstpage_image] =>[orig_patent_app_number] => 12753438
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/753438 | Methods of using anti-TNF antibodies for treating radiation damage to the digestive tract | Apr 1, 2010 | Issued |
Array
(
[id] => 9944209
[patent_doc_number] => 08993509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity'
[patent_app_type] => utility
[patent_app_number] => 13/262094
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27466
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262094
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262094 | Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity | Mar 30, 2010 | Issued |
Array
(
[id] => 7743210
[patent_doc_number] => 20120021440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/262129
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11258
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021440.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262129
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262129 | METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS | Mar 25, 2010 | Abandoned |
Array
(
[id] => 8158407
[patent_doc_number] => 20120100130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Novel Receptor Hetero-Dimers/-Oligomers'
[patent_app_type] => utility
[patent_app_number] => 13/260530
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21571
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100130.pdf
[firstpage_image] =>[orig_patent_app_number] => 13260530
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260530 | Novel Receptor Hetero-Dimers/-Oligomers | Mar 25, 2010 | Abandoned |
Array
(
[id] => 9648802
[patent_doc_number] => 08802815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression'
[patent_app_type] => utility
[patent_app_number] => 13/257332
[patent_app_country] => US
[patent_app_date] => 2010-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6585
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257332 | Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression | Mar 17, 2010 | Issued |
Array
(
[id] => 6383728
[patent_doc_number] => 20100317098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/724169
[patent_app_country] => US
[patent_app_date] => 2010-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22124
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317098.pdf
[firstpage_image] =>[orig_patent_app_number] => 12724169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724169 | Nucleic acid molecules encoding soluble frizzled (FZD) receptors | Mar 14, 2010 | Issued |
Array
(
[id] => 8361141
[patent_doc_number] => 20120216303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/723163
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9343
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/723163 | NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS | Mar 11, 2010 | Abandoned |
Array
(
[id] => 7988321
[patent_doc_number] => 08076456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/721002
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 16310
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076456.pdf
[firstpage_image] =>[orig_patent_app_number] => 12721002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/721002 | Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof | Mar 9, 2010 | Issued |
Array
(
[id] => 6289886
[patent_doc_number] => 20100158908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Stable Polypeptide Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/718898
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24256
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158908.pdf
[firstpage_image] =>[orig_patent_app_number] => 12718898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/718898 | Stable polypeptide formulations | Mar 4, 2010 | Issued |
Array
(
[id] => 8305672
[patent_doc_number] => 08227199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-24
[patent_title] => 'Methods for identifying immunobinders of cell-surface antigens'
[patent_app_type] => utility
[patent_app_number] => 12/710579
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 15984
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12710579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710579 | Methods for identifying immunobinders of cell-surface antigens | Feb 22, 2010 | Issued |
Array
(
[id] => 6434680
[patent_doc_number] => 20100152427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'NUCLEIC ACID ENCODING A NOVEL DP RECEPTOR PROTEIN AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/710556
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29090
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152427.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710556 | NUCLEIC ACID ENCODING A NOVEL DP RECEPTOR PROTEIN AND METHODS OF USE THEREOF | Feb 22, 2010 | Abandoned |
Array
(
[id] => 4639547
[patent_doc_number] => 08017574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues'
[patent_app_type] => utility
[patent_app_number] => 12/700443
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47762
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12700443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/700443 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues | Feb 3, 2010 | Issued |
Array
(
[id] => 7522918
[patent_doc_number] => 08026074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual'
[patent_app_type] => utility
[patent_app_number] => 12/700394
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47771
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12700394
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/700394 | Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual | Feb 3, 2010 | Issued |
Array
(
[id] => 6518836
[patent_doc_number] => 20100203037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'METHODS OF USING GPR119 TO IDENTIFY COMPOUNDS USEFUL FOR INCREASING BONE MASS IN AN INDIVIDUAL'
[patent_app_type] => utility
[patent_app_number] => 12/700423
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47673
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203037.pdf
[firstpage_image] =>[orig_patent_app_number] => 12700423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/700423 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues | Feb 3, 2010 | Issued |
Array
(
[id] => 4629560
[patent_doc_number] => 08008451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Antibodies to TNF (tumor necrosis factor) receptor family members'
[patent_app_type] => utility
[patent_app_number] => 12/697676
[patent_app_country] => US
[patent_app_date] => 2010-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8640
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008451.pdf
[firstpage_image] =>[orig_patent_app_number] => 12697676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/697676 | Antibodies to TNF (tumor necrosis factor) receptor family members | Jan 31, 2010 | Issued |
Array
(
[id] => 4493651
[patent_doc_number] => 07947271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents'
[patent_app_type] => utility
[patent_app_number] => 12/694092
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 22388
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947271.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694092
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694092 | Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents | Jan 25, 2010 | Issued |
Array
(
[id] => 7766192
[patent_doc_number] => 20120034235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker'
[patent_app_type] => utility
[patent_app_number] => 13/145773
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5670
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034235.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145773 | Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker | Jan 21, 2010 | Abandoned |
Array
(
[id] => 6228894
[patent_doc_number] => 20100183632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Antibody Therapy For Modulating Function Of Intestinal Receptors'
[patent_app_type] => utility
[patent_app_number] => 12/687660
[patent_app_country] => US
[patent_app_date] => 2010-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11413
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12687660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687660 | Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity | Jan 13, 2010 | Issued |
Array
(
[id] => 8522235
[patent_doc_number] => 20120321643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/509235
[patent_app_country] => US
[patent_app_date] => 2009-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5021
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509235 | Anti-epidermal growth factor receptor antibodies and uses thereof | Dec 29, 2009 | Issued |
Array
(
[id] => 6411324
[patent_doc_number] => 20100166658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'MONKEY HOMOLOG OF HUMAN ONCOSTATIN M'
[patent_app_type] => utility
[patent_app_number] => 12/648430
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6753
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12648430
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/648430 | Monkey homolog of human oncostatin M and methods of use thereof | Dec 28, 2009 | Issued |